Concerning CT Findings Increase Health Care Utilization With Low-Risk Pulmonary Embolism
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, July 18, 2023 -- Concerning computed tomography (CT) findings among patients with low-risk pulmonary embolism (PE) are associated with increased hospitalization and resource utilization without short-term adverse clinical outcomes, according to a study recently published in JAMA Network Open.
Connor O’Hare, M.D., from the University of Michigan in Ann Arbor, and colleagues examined whether concerning CT findings among patients seen in the emergency department with acute, low-risk PE are associated with differences in treatment and/or clinical outcome. The analysis included 817 adults with PE characterized as high risk or low risk (bilateral central embolus, right ventricle-to-left ventricle ratio greater than 1.0, right ventricle enlargement, septal abnormality, or pulmonary infarction).
The researchers found that 40.5 percent of PEs were low risk and 59.5 percent were high risk by PE Severity Index score. For all low-risk patients, clinical outcomes were similar, with no 30-day deaths in the low-risk group with concerning CTPE findings (0 of 151 patients) versus four of 180 (2.2 percent) in the low-risk group without concerning CT findings and 18.1 percent in the high-risk group. Compared with those without concerning CTPE findings, low-risk patients with concerning CT findings were less frequently discharged from the emergency department (2.0 versus 7.8 percent). Additionally, low-risk patients with concerning findings had more frequent echocardiography (57.6 versus 27.2 percent without concerning findings) and PE response team activation for consideration of advanced therapies (22.5 versus 6.1 percent).
"These findings suggest that concerning computed tomography imaging findings may be a significant barrier to outpatient treatment among patients with otherwise low-risk acute PE," the authors write.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.